Receipt of COVID-19 and seasonal influenza vaccines in California (USA) during the 2021-2022 influenza season.
Receipt of COVID-19 and seasonal influenza vaccines in California (USA) during the 2021-2022 influenza season.
复制标题
DOI：
10.1016/j.vaccine.2022.12.052
复制
发表时间：
2023-02-03
期刊：
影响因子：
5.5
通讯作者：
Pry, Jake M.
中科院分区：
文献类型：
--
作者：
Andrejko, Kristin L.;Myers, Jennifer F.;Openshaw, John;Fukui, Nozomi;Li, Sophia;Watt, James P.;Murray, Erin L.;Hoover, Cora;Lewnard, Joseph A.;Jain, Seema;Pry, Jake M.
Despite lower circulation of influenza virus throughout 2020–2022 during the COVID-19 pandemic, seasonal influenza vaccination has remained a primary tool to reduce influenza-associated illness and death. The relationship between the decision to receive a COVID-19 vaccine and/or an influenza vaccine is not well understood. We assessed predictors of receipt of 2021–2022 influenza vaccine in a secondary analysis of data from a case-control study enrolling individuals who received SARS-CoV-2 testing. We used mixed effects logistic regression to estimate factors associated with receipt of seasonal influenza vaccine. We also constructed multinomial adjusted marginal probability models of being vaccinated for COVID-19 only, seasonal influenza only, or both as compared with receipt of neither vaccination. Among 1261 eligible participants recruited between 22 October 2021–22 June 2022, 43% (545) were vaccinated with both seasonal influenza vaccine and >1 dose of a COVID-19 vaccine, 34% (426) received >1 dose of a COVID-19 vaccine only, 4% (49) received seasonal influenza vaccine only, and 19% (241) received neither vaccine. Receipt of >1 COVID-19 vaccine dose was associated with seasonal influenza vaccination (adjusted odds ratio [aOR]: 3.72; 95% confidence interval [CI]: 2.15–6.43); this association was stronger among participants receiving >1 COVID-19 booster dose (aOR = 16.50 [10.10–26.97]). Compared with participants testing negative for SARS- CoV-2 infection, participants testing positive had lower odds of receipt of 2021-2022 seasonal influenza vaccine (aOR = 0.64 [0.50–0.82]). Recipients of a COVID-19 vaccine were more likely to receive seasonal influenza vaccine during the 2021–2022 season. Factors associated with individuals’ likelihood of receiving COVID-19 and seasonal influenza vaccines will be important to account for in future studies of vaccine effectiveness against both conditions. Participants who tested positive for SARS-CoV-2 in our sample were less likely to have received seasonal influenza vaccine, suggesting an opportunity to offer influenza vaccination before or after a COVID-19 diagnosis.
登录
查看更多内容
DOI：
10.2807/1560-7917.es.2022.27.38.2200720
发表时间：
2022-09
期刊：
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
影响因子：
--
作者：
通讯作者：
--
影响因子：
4.4
作者：
King JP;McLean HQ;Belongia EA
通讯作者：
Belongia EA
影响因子：
13.8
作者：
Siegler AJ;Luisi N;Hall EW;Bradley H;Sanchez T;Lopman BA;Sullivan PS
通讯作者：
Sullivan PS
DOI：
10.15585/mmwr.mm7107e2
发表时间：
2022-02-18
期刊：
MMWR. Morbidity and mortality weekly report
影响因子：
--
作者：
Ferdinands JM;Rao S;Dixon BE;Mitchell PK;DeSilva MB;Irving SA;Lewis N;Natarajan K;Stenehjem E;Grannis SJ;Han J;McEvoy C;Ong TC;Naleway AL;Reese SE;Embi PJ;Dascomb K;Klein NP;Griggs EP;Konatham D;Kharbanda AB;Yang DH;Fadel WF;Grisel N;Goddard K;Patel P;Liao IC;Birch R;Valvi NR;Reynolds S;Arndorfer J;Zerbo O;Dickerson M;Murthy K;Williams J;Bozio CH;Blanton L;Verani JR;Schrag SJ;Dalton AF;Wondimu MH;Link-Gelles R;Azziz-Baumgartner E;Barron MA;Gaglani M;Thompson MG;Fireman B
通讯作者：
Fireman B
影响因子：
5.5
作者：
Saleh OA;Halperin O
通讯作者：
Halperin O